Litcius/Paper detail

Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments

Wataru Takemura, Sho Tashiro, Marina Hayashi, Yuki Igarashi, Xiaoxi Liu, Yuki Mizukami, Nana Kojima, Takumi Morita, Yuki Enoki, Kazuaki Taguchi, Yuta Yokoyama, Tomonori Nakamura, Kazuaki Matsumoto

2021Pharmaceutical Research18 citationsDOI

Topics & Concepts

CefmetazoleIn vivoMinimum inhibitory concentrationPharmacodynamicsPharmacokineticsPharmacologyBeta-lactamaseEscherichia coliAntibioticsCarbapenemIn vitroMicrobiologyChemistryCephalosporinMedicineBiologyBiochemistryGeneBiotechnologyAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyEscherichia coli research studies
Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments | Litcius